Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Click here for the RSS feed for Publications IMB Publications RSS Feed

Publications

Below you will find a list of all IMB Publications. You can filter this list by choosing from the tags on the left and you can select multiple tags if you wish. Before commencing a new search, please ensure you remove any tags/filters you have previously applied by clicking Remove Filters.

You can also search all Publications by entering a keyword(s) in the search box and clicking the Search link.

Search:  Search

Page 1 of 2
Date Title
18/05/2012 Advice on use of wormers in order to control the development of anthelmintic resistance in sheep
17/05/2012 Protopic (tacrolimus) - Important Safety Information from Astellas Pharma Europe as approved by the Irish Medicines Board
11/05/2012 Gilenya (fingolimod) - Important Safety Information from Novartis as approved by the Irish Medicines Board
11/05/2012 Fastum Gel (ketoprofen) - Important Safety Information from Menarini as approved by the Irish Medicines Board
03/05/2012 Drug Safety Newsletter 46th Edition
20/04/2012 Protelos/Osseor (strontium ranelate) - Important safety information from Servier Laboratories (Ireland) as approved by the Irish Medicines Board
20/04/2012 ViaSpan Solution for Organ Preservation - Important Safety Information from Bristol-Myers Squibb Pharmaceuticals as approved by the Irish Medicines Board
19/04/2012 Drug Safety Newsletter 47th Edition
04/04/2012 Field Safety Notice Monthly Summary Sheet - March 2012
03/04/2012 Saizen Solution for Injection (Somatropin) - Important Safety Information from Merck Serono as approved by the Irish Medicines Board
03/04/2012 Tolvaptan (Samsca) - Important Safety Information from Otsuka as approved by the Irish Medicines Board
03/04/2012 Somavert (pegvisomant) - Important Safety Information from Pfizer as approved by the Irish Medicines Board
03/04/2012 CHMP Pharmacovigilance Working Party Monthly Report - March 2012
29/03/2012 Perfalgan (intravenous paracetamol) - Important Safety Information from Bristol-Myers Squibb as approved by the Irish Medicines Board
12/03/2012 Onglyza (saxagliptin) - Important Safety Information from Bristol-Myers Squibb as approved by the Irish Medicines Board
09/03/2012 Benlysta (belimumab) - Important Safety Information from GlaxoSmithKline as approved by the Irish Medicines Board
08/03/2012 Vernakalant (Brinavess) - Important Safety Information from MSD as approved by the Irish Medicines Board
01/03/2012 Field Safety Notice Monthly Summary Sheet - February 2012
27/02/2012 Aliskiren-containing medicinal products - Important Safety Information from Novartis Ireland as approved by the Irish Medicines Board
27/02/2012 CHMP Pharmacovigilance Working Party Monthly report - February 2012
Page 1 of 2



Date Printed: 20 June 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971